Between 13th and 16th November, HIPRA brought together over 30 professionals from the Canadian swine sector at three sessions, the main focus of which was a practical review of the most common reproductive problems in sows. Jennifer Patterson (Swine Research Coordinator University of Alberta) started the presentations with a talk that focused on the gilts’ management, summarizing all the factors that can affect production parameters on a commercial farm. Isaac Rodríguez Ballarà (Regional Technical & Marketing Manager, Hipra) then presented a new approach to the control of infectious reproductive problems, covering diagnosis, management, control and prevention of these under field conditions.

To conclude the sessions, Agustí Camprodon (Brand Manager, Hipra) presented the new vaccine that protects against reproductive losses from Swine Erysipelas and Porcine Parvovirus: ERYSENG® PARVO. It uses Hipramune® G, a state-of-the-art aqueous adjuvant based on ginsenosides to provide a safe vaccine with long-lasting immunity. ERYSENG® PARVO has an exceptional efficacy against Swine Erysipelas providing a 6-month duration of immunity, reducing clinical signs of the disease in sows. It also offers a wide protection against Porcine Parvovirus to cover the entire gestation period. This long-lasting protection can reduce reproductive losses and improve litter size. Finally ERYSENG® PARVO has been shown to minimize body temperature increase after vaccination and have less adverse reactions than competitor vaccines, making it a safe vaccine to administer to gilts and sows prior to breeding.

With the launch of ERYSENG® PARVO in Canada, HIPRA consolidates the SENG range as "the most modern range of vaccines for breeders", and reinforces its commitment to continue growing as the Reference in Prevention for Animal Health.